Blog

DOUGLAS & LONDON SPEARHEADS $1.185 BILLION SETTLEMENT WITH DUPONT TO RESOLVE “FOREVER CHEMICALS” PFAS CONTAMINATION SUITS FOR WATER PROVIDERS

Douglas & LondonEnvironmental Toxic Exposure

New York, New York – Douglas & London, P.C. is proud to announce that DuPont has agreed to pay $1.185 billion to public water systems across the United States that detect PFAS chemicals in their drinking water supplies. The lawsuits allege that DuPont and several other manufacturers sold PFAS-containing products …

Elmiron Bladder Medication Linked to Eye Damage and Vision Loss

Douglas & LondonElmiron

Recent studies have found that patients who have been prescribed and use Elmiron have developed Maculopathy, an eye disorder that can lead to blindness. Early symptoms of Maculopathy include: Having difficulty reading Difficulty of eyes adjusting to darkness Difficulty of seeing close objects Vision becomes dim Spot of vision lost …

Belviq Weight-Loss Drug Has Been Recalled Due to Cancer Risk

Douglas & LondonBelviq

On February 13, 2020, The U.S. Food and Drug Administration (FDA) requested that Japanese pharmaceutical company Eisai remove its weight-loss drugs Belviq and Belviq XR from the market due to findings from a clinical trial showing that long-term use of Belviq was associated with cancer.   The FDA has warned …

  • Page 1 of 5
  • 1
  • 2
  • 3
  • ...
  • 5